28 Jul 2010 10:01
ο»Ώ
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
|||||||||||||
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
ARK THERAPEUTICS GROUP PLC |
||||||||||||
|
2 Reason for the notification (please tick the appropriate box or boxes): |
|||||||||||||
|
Β An acquisition or disposal of voting rights |
Β x |
||||||||||||
|
Β An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||||||||||||
|
Β An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
||||||||||||
|
Β An event changing the breakdown of voting rights |
|
||||||||||||
|
Β Other (please specify): |
|
|
|||||||||||
|
3. Full name of person(s) subject to the notification obligation: Β |
Smith & Williamson Holdings Limited |
||||||||||||
|
4. Full name of shareholder(s) (if different from 3.): Β |
See section 9 |
||||||||||||
|
5. Date of the transaction and date on which the threshold is crossed or reached: Β |
22.07.10 |
||||||||||||
|
6. Date on which issuer notified: Β |
27.07.10 |
||||||||||||
|
7. Threshold(s) that is/are crossed or reached: Β |
5% |
||||||||||||
|
8. Notified details: |
|||||||||||||
|
A: Voting rights attached to shares Β |
|||||||||||||
|
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
|||||||||||
|
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||||||||
|
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||||||||
|
Ordinary GB0034251727 |
Β 10,029,600 |
10,029,600 |
|
|
11,029,600 |
|
5.28% |
||||||
|
|
|||||||||||||
|
B: Financial Instruments |
|||||||||||||
|
Resulting situation after the triggering transaction Β |
|||||||||||||
|
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights Β |
||||||||
|
Β N/A |
|
|
|
|
Nominal |
Delta Β |
|||||||
|
|
|
||||||||||||
|
Total (A+B) Β |
|||||||||||||
|
Number of voting rights |
Percentage of voting rights |
||||||||||||
|
Β 11,029,600 |
5.28% |
||||||||||||
|
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
|||||||||||||
|
Smith and Williamson Nominees Limited, a subsidiary of Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 3,759,600 shares Β Bank of New York Nominees as custodian for Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 1,150,000 shares Β BNP Paribas as custodian for Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 320,000 shares Β BNP Paribas Securities Services as custodian for Smith & Williamson Investment Management (Ireland) Limited, a subsidiary of Smith & Williamson Holdings Limited - 5,625,000 Β |
|||||||||||||
|
Proxy Voting: Β |
|||||||||||||
|
10. Name of the proxy holder: Β |
Β N/A |
||||||||||||
|
11. Number of voting rights proxy holder will cease to hold: Β |
Β N/A |
||||||||||||
|
12. Date on which proxy holder will cease to hold voting rights: Β |
Β N/A |
||||||||||||
|
13. Additional information: Β |
|
||||||||||||
|
14. Contact name: Β |
Stephen Hamilton-Jones, Smith & Williamson Investment Management Limited |
||||||||||||
|
15. Contact telephone number: Β |
020 7131 4734 |
||||||||||||
Β
Follow the stocks